Short Interest in Apyx Medical Co. (NASDAQ:APYX) Grows By 59.8%

Apyx Medical Co. (NASDAQ:APYX) was the target of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 413,600 shares, an increase of 59.8% from the April 30th total of 258,800 shares. Approximately 1.3% of the shares of the stock are sold short. Based on an average trading volume of 183,100 shares, the short-interest ratio is presently 2.3 days.

Hedge Funds Weigh In On Apyx Medical

Several large investors have recently added to or reduced their stakes in APYX. Nantahala Capital Management LLC purchased a new position in Apyx Medical during the fourth quarter worth about $5,008,000. Raymond James Financial Inc. purchased a new position in shares of Apyx Medical in the 4th quarter worth about $134,000. Silverberg Bernstein Capital Management LLC raised its holdings in shares of Apyx Medical by 13.2% in the 1st quarter. Silverberg Bernstein Capital Management LLC now owns 646,569 shares of the company’s stock worth $886,000 after purchasing an additional 75,337 shares during the period. Kingsview Wealth Management LLC raised its holdings in shares of Apyx Medical by 29.5% in the 1st quarter. Kingsview Wealth Management LLC now owns 175,095 shares of the company’s stock worth $240,000 after purchasing an additional 39,850 shares during the period. Finally, Citadel Advisors LLC raised its holdings in shares of Apyx Medical by 130.6% in the 4th quarter. Citadel Advisors LLC now owns 66,355 shares of the company’s stock worth $105,000 after purchasing an additional 37,582 shares during the period. 55.33% of the stock is currently owned by hedge funds and other institutional investors.

Apyx Medical Stock Down 1.3%

APYX opened at $1.58 on Friday. The company has a quick ratio of 4.52, a current ratio of 5.46 and a debt-to-equity ratio of 3.03. The firm has a market cap of $59.71 million, a P/E ratio of -1.90 and a beta of 1.12. Apyx Medical has a 52 week low of $0.76 and a 52 week high of $1.95. The business’s fifty day simple moving average is $1.20 and its 200 day simple moving average is $1.37.

Apyx Medical (NASDAQ:APYX) last released its earnings results on Thursday, May 8th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.03. Apyx Medical had a negative return on equity of 137.98% and a negative net margin of 58.59%. The firm had revenue of $9.43 million for the quarter, compared to the consensus estimate of $9.39 million. As a group, equities research analysts anticipate that Apyx Medical will post -0.68 EPS for the current fiscal year.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.